Skip to content

Clinical trials

Completed Carcinoma, Renal Cell trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Completed Country / region: Japan Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20062
20072
20083
20091
20102
20112
20121
20141
20154
20162
20174
20182
20193
20201
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer9
Bristol-Myers Squibb7
Bayer5
Novartis Pharmaceuticals5
Chugai Pharmaceutical1
Eisai Co., Ltd.1
GlaxoSmithKline1
Hoffmann-La Roche1
Incyte Corporation1
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell36
Kidney Neoplasms8
Neoplasms5
Neoplasm Metastasis3
Carcinoma, Hepatocellular2
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2
Kidney Diseases2
Melanoma2
Squamous Cell Carcinoma of Head and Neck2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.